data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzdoNTEydjM0MS4zMjZIMHoiLz48cGF0aCBmaWxsPSIjRkY5ODExIiBkPSJNMCA4NS4zMzdoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjNkRBNTQ0IiBkPSJNMCAzMTIuODg4aDUxMnYxMTMuNzc1SDB6Ii8+PGNpcmNsZSBmaWxsPSIjMDA1MkI0IiBjeD0iMjU2IiBjeT0iMjU2IiByPSI0My44OTYiLz48Y2lyY2xlIGZpbGw9IiNGRkYiIGN4PSIyNTYiIGN5PSIyNTYiIHI9IjI3LjQzNCIvPjxwYXRoIGZpbGw9IiMwMDUyQjQiIGQ9Ik0yNTYgMjIyLjE0Nmw4LjQ2NCAxOS4xOTUgMjAuODU1LTIuMjY4TDI3Mi45MjcgMjU2bDEyLjM5MiAxNi45MjctMjAuODU1LTIuMjY4TDI1NiAyODkuODU0bC04LjQ2NC0xOS4xOTUtMjAuODU1IDIuMjY4TDIzOS4wNzMgMjU2bC0xMi4zOTItMTYuOTI3IDIwLjg1NSAyLjI2OHoiLz48L3N2Zz4=

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

(NASDAQ:AGLE)

Perks Buy Compare Brokers

$11.88

-0.13[-1.08%]

Last update: 4:08PM (Delayed 15-Minutes)
Get Real Time Here

$11.88

0[0.00%]

After-Hours

Perks Buy Compare Brokers

Open-	Close-
Vol / Avg.0 / 48.059K	Mkt Cap-
Day Range- - -	52 Wk Range2.660 - 24.000

0

Latest News for Stock (NASDAQ:AGLE)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, November 27, 2023

Spyre Therapeutics Will Begin Trading On Nasdaq Under Trading Symbol "SYRE" Effective November 28, 2023; $205M Of Cash, Cash Equivalents, Marketable Securities, And Restricted Cash As Of September 30, 2023, With Expected Runway Into 2026
Benzinga Newsdesk - Nov 27, 2023, 8:43AM
Aeglea BioTherapeutics Announces Name Change To Spyre Therapeutics, Appoints CEO And Additional Directors, And Expands Leadership Team To Develop Next-Generation Therapeutic Combinations For The Treatment Of IBD
Benzinga Newsdesk - Nov 27, 2023, 8:42AM

Monday, September 25, 2023

WuXi Biologics Obligated To Pay A Service Fee And All Non-Cancellable Obligations Specified In Each Work Order, With Termination Possible Upon Completion Of Services Or With Prior Notice For Certain Reasons.
Benzinga Newsdesk - Sep 25, 2023, 4:17PM
Paragon Therapeutics, Inc. And WuXi Biologics Entered Into A Biologics Master Services Agreement, Which Was Later Transferred To Aeglea Biotherapeutics, Inc., Governing Development Activities And Manufacturing For The Company's SPY001 Program
Benzinga Newsdesk - Sep 25, 2023, 4:17PM

Thursday, September 07, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Sep 7, 2023, 9:06AM
Aeglea BioTherapeutics Announces 1-For-25 Reverse Stock Split
Happy Mohamed - Sep 7, 2023, 8:48AM

Tuesday, September 05, 2023

Aeglea BioTherapeutics Appoints Scott Burrows, As CFO; Jonathan Alspaugh, Aeglea's Current President And CFO, Is Expected To Transition Into A Strategic Advisory Consulting Role Through December 31, 2023
Benzinga Newsdesk - Sep 5, 2023, 7:10AM

Thursday, August 24, 2023

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Aug 24, 2023, 5:32PM

Wednesday, August 16, 2023

Wells Fargo Maintains Equal-Weight on Aeglea BioTherapeutics, Raises Price Target to $0.5
Benzinga Newsdesk - Aug 16, 2023, 8:36AM

Tuesday, August 15, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Aug 15, 2023, 5:32PM

Friday, August 11, 2023

Aeglea BioTherapeutics Q2 EPS $(2.27) Misses $(0.15) Estimate, Sales $688.00K Beat $200.00K Estimate
Benzinga Newsdesk - Aug 11, 2023, 7:08AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Aug 1, 2023, 9:06AM

Thursday, July 27, 2023

Aeglea BioTherapeutics Has Agreed To Sell The Global Rights To Pegzilarginase, An Investigational Treatment For The Rare Metabolic Disease Arginase 1 Deficiency To Immedica Pharma For $15M In Upfront Cash And Up To $100M In Contingent Milestone Payments
Benzinga Newsdesk - Jul 27, 2023, 7:18AM

Tuesday, July 25, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Benzinga Insights - Jul 25, 2023, 11:00AM
Stifel Initiates Coverage On Aeglea BioTherapeutics with Buy Rating, Announces Price Target of $0.9
Benzinga Newsdesk - Jul 25, 2023, 5:19AM

Monday, July 24, 2023

10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More
Chris Katje - Jul 24, 2023, 2:05PM

Monday, July 10, 2023

Why Tivic Health Systems Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 10, 2023, 8:11AM

Friday, July 07, 2023

Why Gorilla Technology Group Are Trading Higher By 52%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 7, 2023, 8:12AM

Friday, June 30, 2023

Deep Track Capital Reports A 9.99% Stake In Aeglea BioTherapeutics
Benzinga Newsdesk - Jun 30, 2023, 4:09PM

Friday, June 23, 2023

Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 23, 2023, 8:14AM

Thursday, June 22, 2023

Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
Lisa Levin - Jun 22, 2023, 2:55PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Jun 22, 2023, 1:38PM
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Jun 22, 2023, 1:09PM
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
Lisa Levin - Jun 22, 2023, 12:10PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 22, 2023, 9:12AM
Aeglea BioTherapeutics Stock Surges Over 400% Today - What's Going On
Vandana Singh - Jun 22, 2023, 8:59AM
Aeglea BioTherapeutics shares are trading higher after the company announced acquisition Of Spyre Therapeutics and concurrent oversubscribed $210M private investment positions
Benzinga Newsdesk - Jun 22, 2023, 8:32AM
Aeglea BioTherapeutics Announces Acquisition Of Spyre Therapeutics And Concurrent Oversubscribed $210M Private Investment Positions The Company
Bill Haddad - Jun 22, 2023, 8:20AM
Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 22, 2023, 7:51AM

Monday, June 05, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Jun 5, 2023, 12:23PM

Tuesday, May 30, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - May 30, 2023, 2:13PM

Thursday, May 11, 2023

Recap: Aeglea BioTherapeutics Q1 Earnings
Benzinga Insights - May 11, 2023, 8:30AM
Aeglea BioTherapeutics Q1 EPS $(0.20) Misses $(0.18) Estimate, Sales $198.00K Beat $120.00K Estimate
Benzinga Newsdesk - May 11, 2023, 7:37AM

Friday, April 21, 2023

Why Sidus Space Shares Are Trading Lower By Around 24%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Apr 21, 2023, 8:00AM

Monday, April 17, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Apr 17, 2023, 1:42PM

Friday, April 14, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Apr 14, 2023, 1:09PM

Wednesday, April 12, 2023

Crude Oil Rises Over 2%; Cutera Shares Plummet
Lisa Levin - Apr 12, 2023, 3:26PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Apr 12, 2023, 1:31PM
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Apr 12, 2023, 12:47PM
Nasdaq Edges Higher; US Crude Oil Inventories Increase Last Week
Lisa Levin - Apr 12, 2023, 12:32PM
Why Are Aeglea BioTherapeutics Shares Sinking Today?
Vandana Singh - Apr 12, 2023, 12:13PM
LifeSci Capital Downgrades Aeglea BioTherapeutics to Market Perform
Benzinga Newsdesk - Apr 12, 2023, 11:36AM
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Benzinga Insights - Apr 12, 2023, 11:00AM
JonesTrading Downgrades Aeglea BioTherapeutics to Hold
Benzinga Newsdesk - Apr 12, 2023, 9:22AM
Aeglea Bio Therapeutics Inc Says On April 8, Co's Board Approved Restructuring Of Company's Workforce
Happy Mohamed - Apr 12, 2023, 9:07AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Apr 12, 2023, 9:06AM
Aeglea BioTherapeutics shares are trading lower after the company announced interim results the ongoing Phase 1/2 clinical trial of pegtarviliase for the treatment of Classical Homocystinuria and said it is exploring strategic alternatives.
Benzinga Newsdesk - Apr 12, 2023, 8:29AM
Aeglea Biotherapeutics Announced Interim Results From The Phase 1/2 Trial Of Pegtarviliase Classical Homocystinuria. Following Its Review Of The Interim Results, The Company Announced That It Is Exploring Strategic Alternatives
Benzinga Newsdesk - Apr 12, 2023, 7:10AM

Monday, April 03, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Apr 3, 2023, 1:36PM

Friday, March 31, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Mar 31, 2023, 11:46AM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved